Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association, discusses pharmacists’ role in diabetes and CKD care at ASN Kidney Week 2026.
|Videos|March 17, 2015
What Pharmacists can do to Promote Medication Synchronization Programs
Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about what pharmacists can do to promote medication synchronization programs.
Advertisement
Jason Turner, PharmD, owner of Moundsville Pharmacy, talks about what pharmacists can do to promote medication synchronization programs.
This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.
Advertisement
Related to this article
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
In a Korean cohort of 1861 patients with nondialysis CKD, intake below 0.6 g/kg/d was linked to more kidney failure and higher all-cause mortality.
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Diabetes Awareness Month Opens Amid New T1D, T2D Approvals
2
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Kidney Week 2026: Pharmacists' Growing Role in Kidney Care
4
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
5